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Abstract
Background: With ever increasing accessibility to high throughput technologies,
more complex treatment structures can be assessed in a variety of ’omics
applications. This adds an extra layer of complexity to the analysis and
interpretation, in particular when inferential univariate methods are applied en
masse. It is well-known that mass univariate testing suffers from multiplicity
issues and although this has been well documented for simple comparative tests,
few approaches have focussed on more complex explanatory structures.
Results: Two frameworks are introduced incorporating corrections for multiplicity
whilst maintaining appropriate structure in the explanatory variables. Within this
paradigm, a choice has to be made as to whether multiplicity corrections should
be applied to the saturated model, putting emphasis on controlling the rate of
false positives, or to the predictive model, where emphasis is on model selection.
This choice has implications for both the ranking and selection of the response
variables identified as differentially expressed. The theoretical difference is
demonstrated between the two approaches along with an empirical study of lipid
composition in Arabidopsis under differing levels of salt stress.
Conclusions: Multiplicity corrections have an inherent weakness when the full
explanatory structure is not properly incorporated. Although a unifying ‘single
best’ recommendation is not provided, two reasonable alternatives are provided
and the applicability of these approaches is discussed for different scenarios where
the aims of analysis will differ. The key result is that the point at which
multiplicity is incorporated into the analysis will fundamentally change the
interpretation of the results, and the choice of approach should therefore be
driven by the specific aims of the experiment.
Keywords: multiplicity; model selection; ’omics; ANOVA
Background
Multivariate data are frequently generated within biological applications due to
the ever increasing availability of high-throughput technologies to study functional
genomics using transcriptomics, proteomics, lipidomics and metabolomics. These
technologies generate data from large numbers of response variables, and typically
interest is focussed on identifying the ‘important’ response variables, where impor-
tant will be a context specific definition. For instance, experiments may be designed
with a specific explanatory structure, such as the inclusion of treatment factors,
blocking factors or observational covariates, where important variables might be
those for which different (combinations of) treatment levels show statistically sig-
nificant different responses. It is indisputable that this explanatory structure infor-
mation should be incorporated into the subsequent statistical analysis. However,
this is not always straightforward to achieve. This is exemplified in a study of the
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lipid composition of Arabidopsis thaliana under differing treatment combinations,
constructed as a replicated 4x3 factorial design for different Arabidopsis genotypes
(Columbia, Shadara, Ta-0 and Eutrema) under three differing levels of salt stress (0,
100, 200 nM NaCl). In total, the abundance of 131 lipids (response variables) was
measured in each condition. The log2 abundance over these conditions for the differ-
ent lipid species is shown in Figure 1A. Interest might be focussed on lipids showing
significant differences between different genotypes, salt stresses or combinations of
these.
There are two main avenues of analytical methods that can be applied to such
’omics data; multivariate methods and mass univariate methods (see e.g. [1, 2]).
Each have their own advantages and disadvantages, but in combination can elicit
a great deal of insight into the underlying mechanisms that generated the data [3–
7]. In this paper, we predominantly focus on the issues that arise in the latter
methods, the mass-univariate approach, but would like to emphasise that these
methods should add to the insight obtained from multivariate approaches rather
than act as a replacement.
Mass univariate analysis
In contrast to multivariate approaches, mass univariate methods investigate each re-
sponse variable independently. Although the covariance structure between response
variables is not accounted for in such an analysis, this approach will provide infor-
mation about the variability in individual response variables, and, in particular, how
it relates to components of the explanatory structure. For example, identifying the
sets of treatment conditions that are statistically significant for each response. This
is particularly advantageous when an experiment may include complex explanatory
structures that include multiple explanatory terms. Standard statistical techniques
such as ANOVA (analysis of variance), REML (restricted maximum likelihood)
and regression can be used to investigate both the biological size and statistical
significance of different explanatory model components in an inferential framework.
Moreover, these analysis approaches can cope with complex treatment structures
(such as the factorial treatment structure in the above example), unbalanced design
structures and missing values.
In generality, it is of interest to fit and analyse the following linear model,
yi = Xiβ + i, for i = 1, ..., n (1)
i ∼ N(0, σ2),
where n is the number of observations, yi is the ith observation of a single response
variable y, Xi is the ith row of the design matrix X, β is the vector of coefficients to
be estimated and  are independent error terms. Fitting and analysing such models
is a completely standard statistical approach using the methods identified above.
However, there are issues in applying such methods en masse to many different
response variables in the same dataset. To illustrate this, let us first consider the
simple example where the design matrix X corresponds to a single explanatory
factor. Specifically, suppose
yji = βj + ji, i = 1, ..., nj , j = 1, ..., J (2)
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where yji is the ith observation on the jth treatment. Once fitted, the estimated
parameters of this model can be assessed. Specifically, using either a two-sample
t-test (for J = 2) or an F-test (for J > 2) the null hypothesis of no difference
in response in the J different treatments can be tested. When testing at a pre-
specified significance level, α, of 0.05, the probability of a type I error (the false
positive rate) is controlled at 5%. However, it is well known that applying such a
univariate analysis approach, en masse, to multiple response variables, will result in
an unacceptably high type I error rate over the whole experiment due to the issue
of multiple testing (also referred to as multiplicity), described below.
Multiple testing
In a multiple testing scenario, the probability of a type I error, or false positive (i.e.
the probability of rejecting the null hypothesis when the null hypothesis is true) over
the tests for the complete set of response variables is inflated. For example, consider
making independent hypothesis tests for 10 (independent) response variables, the
probability of making at least one type I error, α∗, is given by,
α∗ = Prob(at least 1 type I error)
= 1− Prob(no type I error)
= 1− (1− α)10,
which when the individual level of significance is α = 0.05, gives α∗ = 0.40. Thus,
to control the overall probability over R tests (the number of response variables)
of at least one type I error at a specified level α, the significance level for each test
becomes 1−(1−α)1/R, which in practice is often approximated by the upper bound
α/R, the Bonferroni correction. This adjustment controls the family wise error rate
(FWER), defined to be the probability of at least one type I error. Alternative ways
of controlling the type I error in a multiplicity framework include controlling the
per-family error rate (PFER), which is defined to be the expected number of type
I errors, and the false discovery rate (FDR), defined as the expected proportion of
false discoveries. A plethora of methods for controlling the type I error, through
differing multiple testing corrections, can be found in the literature (see [8, 9] and
[10] for reviews). These often have different aims, such as which error rate is to be
controlled, whether or not tests can be considered independent and whether the
chosen error rate should be controlled in the strong or weak sense [8].
It is reasonable in an ’omics framework to assume there will be substantial posi-
tive dependence between response variables. This means that any correction based
on the assumption of independent tests will be highly conservative and will conse-
quently reduce the power of the test for fixed sample sizes. Alternative procedures
are available that account for this dependence, for example [11] employed resampling
methods and [12–14] adjusted the significance level based on an effective number of
independent tests Neff < N .
Where there is only a single explanatory variable in the model, as in equation
(2), any of the above multiplicity corrections can be incorporated without difficulty
to ensure the overall type I error rate of the whole experiment does not become
over-inflated.
Hassall and Mead Page 4 of 19
Incorporating explanatory structures
However, there is a lack of coherence within the literature when explanatory struc-
tures become more complex. As the cost of ’omics experiments decreases, exper-
imenters are increasingly generating ’omics datasets from experiments with more
complex designs, including both crossed and nested treatment structures. Examples
can be found in transcriptomics [15–17], proteomics [18, 19] and metabolomics (as
exemplified from the open source database PMR [20]). In all of these scenarios,
mass univariate analysis can be applied to investigate the effect of the explanatory
structure on a response-by-response basis.
Consider, the salt stress lipidomics example. For a single response variable, the
associated linear model takes the form,
yjki = µ+ aj + bk + (ab)jk + jki, for j = 1, ..., 4; k = 1, ..., 3 (3)
jki ∼ N(0, σ2),
where yjki is the response due to the ith observation on the jth genotype for the
kth salt stress, aj is the effect associated with genotype j, bk is the effect associated
with salt level k, (ab)jk is the interaction effect of genotype j and salt level k and
 are independent error terms.
For a single response variable (e.g. lipid TAG 52.6), the corresponding analysis
would be done using ANOVA to produce the following table,
Df Sum Sq Mean Sq F value Pr(>F)
genotype 3 27.503 9.168 38.230 < 0.001
salt 2 11.852 5.926 24.711 < 0.001
genotype:salt 6 2.328 0.388 1.618 0.171
residual 36 8.633 0.240
This provides an assessment of the statistical significance of the three individ-
ual terms, through independent tests, according to the explanatory model given in
equation (3). The question then arises as to how to apply the multiplicity correction
when applying such an analysis to multiple response variables. All developed multi-
plicity correction approaches are only appropriate for correcting a single hypothesis
test per response variable as in the example corresponding to equation (2). Thus to
directly apply these multiplicity corrections, the complex treatment structure would
have to be ignored and the multiplicity correction instead applied to the one-way
unstructured analysis. For the salt stress lipidomics example, this corresponds to
the analysis of the one-way (unstructured) treatment term in the following linear
model:
yjki = µjk + jki, for j = 1, ..., 4; k = 1, ..., 3 (4)
jki ∼ N(0, σ2),
where µjk is the mean response for genotype j and salt level k. The associated
ANOVA table is given by,
This analysis clearly fails to exploit the factorial treatment structure included in
the design of the experiment, providing no information about the relative sizes and
importance of the two main effects and the interaction effect.
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Df Sum Sq Mean Sq F value Pr(>F)
genotype:salt 11 41.682 3.789 15.802 < 0.001
residual 36 8.633 0.240
In recent years, developments in two-stage or hierarchical hypothesis testing [21]
have gone some way to addressing these issues. In this framework, a family of hy-
potheses and tests are associated with each response variable. In the first stage
an overall test of the combined effects of all explanatory variables is considered,
with more detailed, individual hypotheses of interest only considered where this
first overall test gives a significant result. In this way the overall false discovery rate
(OFDR) [22] can be controlled across all response variables. Examples using such
an approach include the analysis of data from microarray gene expression studies
with multiple treatments [23] where at the first stage the OFDR is controlled for the
overall F-test resulting from a one-way ANOVA for each gene. Subsequently, at the
second stage of testing, ad-hoc pairwise comparisons of interest between treatments
are considered only for genes having a multiplicity-corrected significant result for
the overall test (potentially requiring further corrections for multiple comparisons).
Two similar approaches (referred to as a nested F and a hierarchical F method) are
implemented in the decideTests function of the limma package [24] for differential
expression analysis of microarray and RNAseq data. Heller et al. [25] also consid-
ered a two-stage approach for the analysis of data from microarray gene expression
studies, but here the first stage considered the overall analysis for a gene set, with
the OFDR controlled at the gene set level, and the second stage then assessing
individual genes within those gene sets initially identified as showing significant
results. More recently, Van den Berge et al. [26] extend this concept to RNAseq
data to account for factorial treatment structures. Although these approaches en-
able multiplicity to be controlled at the appropriate level, i.e. at the level of a gene
or set of genes rather than at the hypothesis level, or in our case at the response
variable level, the second stage of testing is not always fully satisfactory. The ex-
amples above all focus the second stage testing on pairwise comparisons requiring a
second multiplicity control of the FWER and therefore a reduced power compared
to that achieved when fully exploiting the explanatory structure. We extend these
approaches by exploiting the full structure of the explanatory model both at the
first and second stage of testing. Moreover, we focus on developing visualisations
from the output of such approaches in order to explicitly investigate the structure
of the data. Explicitly, we aim to provide mass univariate analysis approaches that
can both:
– identify which response variables show significant levels of variation due to
the explanatory model (taking account of multiplicity), and
– assess how these response variables are important by identifying the compo-
nents of the explanatory model showing significant effects.
In the following, we present a general paradigm of analysis, through which we
develop the theory behind two methods for incorporating a multiplicity correction
within the general linear model framework. This is supported by a simulation study
before demonstrating the methods on an application in lipidomics, where we inves-
tigate the biological understanding that can be gained from such an approach. We
end with a discussion on the methods, highlighting current limitations and possible
extensions.
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Methods
Typically, linear models as defined in (1) are used both to estimate the effects
due to individual explanatory variables (or the interactions between two or more
explanatory variables), and to test the statistical significance of these effects. For
the analysis of a designed experiment, it is conventional to fit the saturated (or
maximal) model, and it is important to make a distinction between this model
and the predictive model, used to generate predictions for different combinations
of the explanatory variables (usually factors). The saturated model includes all of
the explanatory terms associated with the factors included in the design of the
experiment, and provides the basis for assessing the statistical significance of each
of these terms (blocking factors, main effects of treatment factors and interaction
effects between two or more treatment factors). Having determined the statistically
significant effects relative to the estimated background (observation-to-observation)
variability, the predictive model can be formed, containing all statistically significant
terms plus terms that are marginal to these (i.e. both main effects must be included
in the predictive model if the associated interaction effect is statistically significant).
Where an experiment is carefully designed to be balanced and orthogonal, this
selection of the predictive model is straightforward as all terms in the saturated
model will be independent. For more general explanatory structures, it may be
more difficult to define a saturated model, so that the fitted model will usually be
the predictive model.
In both scenarios, the identification of the terms in the predictive model can be
achieved in multiple ways; such as using F-tests to assess individual explanatory
terms, likelihood ratio tests to compare nested models, or the minimisation of an
information criterion. In some cases these approaches will be equivalent. Note that,
with the exception of model selection via information criteria, all methods rely
on a predefined level of statistical significance at which to perform the test used to
include or omit a term from the predictive model. In these scenarios, selection of the
predictive model will identify the statistically significant explanatory terms for each
response variable. Thus, we consider the incorporation of multiplicity correction and
the selection of a response-specific predictive model in a number of different ways.
The process for achieving this can be split into three steps,
– A ranking of responses in order of significance [RANK]
– A filtering process to discard non-significant responses (incorporating correc-
tions for multiplicity) [FILTER]
– A model selection step to define the predictive model (i.e. to choose the im-
portant terms in the explanatory structure) for each response [MODEL].
The order in which these steps are implemented will depend upon the aims of the
study.
Approach 1: Rank, filter, model (RFM)
Firstly, we consider the RFM approach, where responses are ranked, filtered and
then modelled. Explicitly, this approach can be viewed as an extension to the one-
way multiplicity corrections of equation (4), and consists of the following steps:
1 For each of the n response variables, fit the linear model with a single one-way
(unstructured) treatment term and calculate the associated one-way ANOVA
as in example (4) to obtain an overall test of significance at this first step.
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2 Rank the responses based on the significance of this overall test and apply a
multiplicity correction of choice to this set of n tests.
3 Filter out the responses deemed non-significant after the multiplicity correc-
tion.
4 For the remaining response variables, apply a model selection process to the
full explanatory structure, generating a predictive model for each significant
response variable.
This process is depicted in Figure 2A. Since there are a finite number of possible
models, responses can be grouped according to the set of significant terms in the pre-
dictive model. In the case that model selection is done via information criteria, this
is a simple extension to current methods, which enables the underlying explanatory
structure in each response to be further investigated. If however, model selection is
applied via a testing procedure, such as likelihood ratio tests or F-tests, then careful
consideration of the chosen level of significance is required. Specifically, in order to
make consistent comparisons, the significance level for the model selection step for
each response should be adjusted according to the multiplicity correction in step 2.
To be explicit, let p(1), ..., p(R) be the unadjusted p-values for the responses 1...R of
the one-way F-test in step 1. After a multiplicity correction in step 2, the adjusted p-
values are given by max(1, c(1)p(1)), ...,max(1, c(R)p(R)), where c(r) is the adjustment
applied to the p-value for response r (e.g. under a Bonferroni correction c(r) =
R, ∀r ∈ {1...R}). Equivalently, the significance level, the probability of a type I
error, has also been adjusted by 1/c(r), which under a Bonferroni correction is 1/R.
Thus, each response is assessed against a specific significance level α/c(r), r = 1...R.
This response specific significance level is carried through to step 3 and is the
significance level used in the model selection step.
Approach 2: Model, rank, filter (MRF)
An alternative approach is the MRF approach, which starts with the model selection
step and filters the response variables based on an overall test of the predictive
model. Explicitly, this consists of the following steps,
1 For each response variable, apply a model selection process to the full ex-
planatory structure. This will then define specific explanatory structures for
each response, yielding the predictive model for each of the n responses. Note,
no multiplicity correction is applied at this step as the aim is to construct a
predictive model for each response based on a consistent measure of signifi-
cance.
2 For each response-specific predictive model, obtain the associated one-way
(unstructured) treatment term and fit the corresponding linear model that
has a single treatment term to obtain an overall test of significance through
a one-way ANOVA.
3 Rank the responses based on the significance of this overall test and apply a
multiplicity correction of choice to this set of n tests.
4 Filter out the response variables deemed non-significant after the multiplicity
correction.
This is depicted in Figure 2B. As with RFM, this will result in different responses
having different significant explanatory variables and hence can be used to classify
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responses according to their final explanatory structure. However, in contrast to
RFM, the model selection step in MRF, regardless of which method used, will be
consistent across all response variables, whilst the overall test for significance will
differ. Since this test is applied after model selection, models for different response
variables will have a differing number of explanatory terms and as such the overall
F-test will have response-specific numerator and denominator degrees of freedom.
A comparison
Although the general framework is very similar for incorporating multiplicity cor-
rections and model selection in these two approaches, they give fundamentally dif-
ferent classifications of the response variables. The approach that should be used
will depend on the scenario in question. In the case of balanced orthogonal designs,
where all model terms are either blocking or treatment factors, the RFM approach
seems favourable as the multiplicity correction is applied to the saturated model.
In a regression framework, where model terms may include observational variables,
intuitively model selection is more important, motivating the use of MRF which
puts more emphasis on the model selection process.
To illustrate where differences occur between the two approaches, consider the
example of a designed experiment consisting of a two factor (A and B) tA x tB
factorial treatment structure (with no blocking structure). The saturated model is
given by,
yjki = aj + bk + (ab)jk + jki, (5)
with corresponding ANOVA table,
df SS MS F
A (tA − 1) SSA 1(tA−1)SSA MSA/MSres
B (tB − 1) SSB 1(tB−1)SSB MSB/MSres
A:B (tA − 1)(tB − 1) SSAB 1(tA−1)(tB−1)SSAB MSAB/MSres
residual N − tAtB SSres 1(N−tAtB)SSres
Under RFM, the overall significance test is based on the one-way ANOVA and is
given by the test statistic,
FA∗B =
(SSA + SSB + SSAB)/(tAtB − 1)
SSres/(N − tAtB)
=
N − tAtB
tAtB − 1 ×
(
SSA
SSres
+
SSB
SSres
+
SSAB
SSres
)
,
where under the null hypothesis that there is no difference between the tA × tB
different treatments, FA∗B ∼ FtAtB−1,N−tAtB .
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Now, let us assume that the interaction term in the two-way structured ANOVA
is not significant, i.e. the F statistic given by,
FA:B =
SSAB/((tA − 1)(tB − 1))
SSres/(N − tAtB)
=
N − tAtB
(tA − 1)(tB − 1) ×
(
SSAB
SSres
)
,
is less than the 5% critical value (FA:B < F
[0.05]
(tA−1)(tB−1),N−tAtB). Then under the
MRF procedure, the interaction term is dropped from the predictive model and the
overall assessment of significance is based on the test statistic,
FA+B =
N − (tA + tB)
tA + tB − 1 ×
(
SSA
SSres + SSAB
+
SSB
SSres + SSAB
)
,
on tA + tB − 1 and N − (tA + tB) degrees of freedom.
Thus, the overall test statistic under RFM (given by FA∗B) can be directly related
to the overall test statistic under MRF (given by FA+B), see Section 1 of the
Supplementary Material in Additional file 1 for details. This relationship is shown
in Figure 2C for tA = 4, tB = 3, N = 36 and overall F-statistic of FA∗B = 2, which
implies an associated p-value of pA∗B = 0.075. Thus, regardless of the significance of
any individual main effects, under RFM this response variable would be filtered out
as being non-significant. However, as can be seen in Figure 2C, when the interaction
term is sufficiently non-significant (and consequently one or more main effects are
highly significant since the overall variance ratio is fixed at 2), MRF would correctly
identify a significant response variable. Thus, RFM is a conservative approach that
has the potential for prematurely filtering out responses.
By moving the filtering step of the RFM approach to post-model selection step
(i.e. a rank model filter (RMF) approach as described in Additional file 1 of the
Supplementary Material), this conservativeness can be mitigated, but ranking in
the first step will, in general, result in a more conservative multiplicity correction
compared to the MRF approach that applies multiplicity corrections to the one-way
test of the predictive model associated with larger residual degrees of freedom.
Results
The methods derived above are demonstrated and compared through a compre-
hensive simulation study before being applied to the lipidomics dataset previously
described. For this dataset, we also consider in detail the interpretation of such
analyses through the presentation and visualisation of the output.
Simulation study
In order to comprehensively compare these methods, our simulation study consid-
ered three different designs (a 2×2 factorial treatment structure, a 3×2×4 factorial
treatment structure and a 3× 2× 4 factorial treatment structure with an imposed
randomized complete block structure). For each design, we varied the number of
responses (500, 1000 and 20000), the number of replicates (3, 4 and 5) and the
multiplicity control (FDR via Benjamini-Hochberg and FWER via Bonferroni). In
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addition, for the randomized complete block design responses were simulated with
a block diagonal dependence structure. Each scenario was simulated 50 times in
order to obtain representative estimates of the achieved error rates under the two
methods of interest (RFM and MRF). Thus, in total, 1350 datasets were simulated
covering a range of design scenarios, each of which was analysed via the following
four methods.
1 RFM, with Benjamini-Hochberg (B-H) multiplicity correction controlling the
FDR at 5% and model selection via F-tests
2 MRF, with Benjamini-Hochberg multiplicity correction controlling the FDR
at 5% and model selection via F-tests
3 RFM, with Bonferroni multiplicity correction controlling the FWER at 5%
and model selection via F-tests
4 MRF, with Bonferroni multiplicity correction controlling the FWER at 5%
and model selection via F-tests
To compare the RFM and MRF approaches, we investigated the observed error rates
within the simulation study. Throughout, we focus our discussion to the analysis
under a B-H multiplicity correction. Further discussion under a Bonferroni multi-
plicity correction is given in Section 3.3 of the Supplementary Material in Additional
file 1.
Figure 3A shows the distribution of the percentage of false positives (out of a
total of R responses) for each simulation scenario. From this, it can be seen that
under the MRF, more false positives are detected than under the RFM. However,
both methods appear to control the FDR (as shown empirically in Section 3.2
of the Supplementary Material in Additional file 1). As the number of responses
increases, the distribution of error rates tightens with little difference observed as the
sample size increases. Moreover, it is clear that where there is a strong dependence
structure between responses there is a greater variability in the type I error rate
obtained under the MRF. Since model selection is emphasised under the MRF, this
approach would likely benefit by taking explicit account of the dependence structure
in the modelling step, for example through a hierarchical approach. The distribution
of the percentage of false negatives (the number of responses falsely identified as
non-significant out of a total of R responses) is shown in Figure 3B. Under the
MRF, fewer false negatives are detected than under the RFM as predicted from
Figure 2C. Moreover, it can clearly be seen that as the power of the tests increase
for larger sample sizes and more complex experiments, the rate of false negatives
decreases.
However, the identification (or mis-identification) of overall significance is not
the only error we can consider. Figure 4 shows the rate of model misspecification
under the RFM and MRF approaches. There is a tendency for the MRF to have a
higher rate of correct model specification in the 2× 2 design structure compared to
the RFM. Moreover, the MRF appears slightly worse under a 3 × 2 × 4 structure,
although this difference is diminished under a Bonferroni multiplicity correction
(Section 3.3 of the Supplementary Material in Additional file 1). Both methods
have a higher rate of over-fitting compared to the rate of under-fitting for the more
complex design structure (Figures 4C and D). Moreover, in these more complex
design scenarios, the RFM generally has a higher rate of under-fitting than the
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MRF (Figure 4D) providing a more parsimonious representation of the response
but at the cost of a conservative filtering of overall differential expression.
Case study: Lipidomics
Applying both RFM and MRF under a B-H correction to control the FDR to the
lipidomics dataset described previously, only minor differences in the number of
lipids identified as showing differential expression can be seen. Specifically, of the
131 lipids, 129 were identified as showing differential expression between treatments
under RFM, whilst under MRF all 131 lipids were identified. However, discrepancies
between the methods become apparent when assessing the selected predictive model,
with around 4% fewer lipids found to have a significant interaction term under RFM
compared with MRF. These differences were exacerbated with the application of a
more stringent Bonferroni correction (not shown).
Although the identification of ‘significant’ response variables is useful, greater in-
sight can always be gained by coupling the notion of statistical significance to bio-
logical relevance. Within the ’omics framework, it is common to use high throughput
technologies to identify a list of the most ‘interesting’ response variables to inves-
tigate further. In the simplest case, where comparisons are only made between two
treatment conditions, comparisons are often visualised through volcano plots, which
show the relationship between statistical significance (often scaled logarithmically)
and biological relevance (often presented in terms of fold change to a baseline con-
dition). This enables easy identification of the ‘most interesting’ responses that are
both statistically significant and biologically relevant. However, for more complex
explanatory (treatment) structures, it is far from clear how to identify ‘interesting’
responses.
Overall assessment
In both the RFM and MRF approaches, a one-way F-test is applied to obtain
an overall level of significance. The meaning of this one-way test is fundamentally
different in the two approaches since under RFM, it is a test of the saturated
model, whereas under MRF, it is a test of the predictive model. Nevertheless, this
measure of statistical significance can be used to rank responses. Figure 5 shows the
discrepancy in the ranking of responses from the two methods, with RFM giving a
greater rank to response variables with significant interaction components, whilst
MRF gives greater rank to responses with parsimonious predictive models (relative
to the corresponding saturated model).
In addition, these approaches can be used to characterise the response variables
through the identified predictive model. For example, the lipidomics response vari-
ables can be categorised into 8 different groups, where each group contains response
variables with the same predictive model. As shown in the simulation study, the
predictive models identified by the two approaches differ and so different categori-
sations of the response variables are obtained as shown in Figures 5C and 5E.
More meaningful insight can be obtained by coupling these overall measures of
significance with measures of biological relevance. One approach to obtaining mea-
sures of biological relevance is through predictions obtained from the predictive
model selected in the two-step analysis procedures. Since an overall assessment of
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significance based on the saturated model (as under RFM) may have very little rele-
vance to predictions from the predictive model, the overall assessment of significance
based on the predictive model (as under MRF) should be used.
Model predictions are a useful way of defining biological relevance, for example
through the predicted fold change between two treatment conditions. However,
when there are more than two treatment conditions multiple measures of biological
relevance can be obtained and the most meaningful comparisons will be context
specific. For example, the treatment condition of the Arabidopsis variety Columbia
under no salt stress can be considered as a baseline or default status. In this scenario,
a measure of biological relevance can be obtained as the predicted fold change
(in each treatment condition) from the baseline level. This results in a series of
pairwise comparisons to a baseline and can be represented through a set of volcano
plots (Figure 6A) where the measure of significance is constant across all plots, but
with each subplot reflecting the fold change from baseline due to each individual
treatment condition. Consequently, the set of ‘important’ response variables can be
identified as those that are statistically significant overall and have a fold change
greater than some threshold in at least one treatment relative to the baseline. From
this, it can be seen that the conditions identifying the greatest number of ‘important’
response variables are associated with differences in lipid abundance between the
genotype Eutrema compared to the abundance in the genotype Columbia. However,
these pairwise comparisons make no use of the explanatory structure and it is
arguably more appropriate either to obtain a structured summary (see below) or
to obtain a single overall measure of biological relevance. For example, Figure 6B
shows two volcano plots, where biological relevance is calculated as the maximal
fold increase (and decrease) in any treatment condition compared to the baseline,
thus giving a single ranking of ‘importance’ over the response variables.
It is important to emphasise that the (biologically relevant measures of) differences
are not necessarily statistically significant, and that the aim here is to produce
a ranking considering a measure of overall statistical significance coupled with a
notion of overall biological relevance. For example, lipid X30.0 is considered to be
important as it shows both differential expression (a statistically significant one-way
analysis) and the largest fold increase in any treatment condition compared to the
baseline of no salt stress in Columbia.
Marginal assessment
With a complex treatment structure, it will usually be preferable to assess sta-
tistical significance for particular treatment terms in the linear model in order to
answer specific questions associated with the design of the treatment structure. In
a univariate framework, there are three approaches to do this;
1 Assess individual model terms through the appropriately structured ANOVA
(or equivalent analysis framework),
2 Incorporate a set of orthogonal contrasts into the treatment structure of the
linear model and assess these terms (e.g. through ANOVA),
3 Compare predicted means through pairwise t-tests (also referred to as multiple
comparisons or post-hoc tests).
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In what follows, we consider extensions of only the first two approaches to the mass
univariate framework. There are a multitude of reasons for not considering the third
(see, for example, references and discussion in Chapter 8 of [27]).
Since such a marginal assessment will be focussed on the statistical significance
of individual model terms, multiplicity corrections should be applied before the
predictive model selection. Consequently, for such marginal assessments, the RFM
approach is more appropriate.
In contrast to the overall assessments of the previous section, it is now of interest
to make multiple assessments for each response variable. For example, consider
the subset of lipids found to have two significant main effects but no significant
interaction (under RFM). The response variables can be ranked by the significance
of the first factor (the variety effect) and also by the significance of the second factor
(the salt effect). Unsurprisingly, these give very different rankings of the lipids, both
of which are of biological interest. To give meaning to these measures of statistical
significance, an associated measure of biological relevance is required. For a two-
level factor, this is straightforward and simply results in the standard volcano plot
of difference (often presented in fold change) vs. significance. For a factor with
more than two levels, a similar approach to the overall assessment could be used.
For instance defining relevance as a maximal fold change to a baseline or, where
no baseline exists, the maximal fold change between pairs of treatment conditions.
However, neither of these approaches maintain the factor definition of a marginal
assessment. A natural alternative is to generalise the notion of biological relevance
from simple comparative predictions to estimated effects. Explicitly, relevance can
be defined by
√
MST , where MST is the mean square for the explanatory term T . A
larger value of the treatment mean square indicates a greater variation in the mean
response of the levels of the treatment factor. Consequently, a biologically relevant
threshold, ThresB , can be defined such that only response variables showing a
MST > Thres
B are deemed relevant. Moreover, under the RFM, each treatment
mean square is explicitly tested against the null hypothesis that MST /MSres = 1
at a significance level corrected for multiplicity according to the associated one-
way analysis. Since the residual mean square, MSres, is an estimate of background
variation, this hypothesis test provides the corresponding assessment of statistical
significance having adjusted for multiplicity. Thus, a generalisation of the volcano
plot is obtained (Figure 7A) for individual explanatory terms.
In addition, the adjusted p-values for each treatment term can be obtained for each
response variable. This is shown for the lipidomic data in Figure 7B, where lipids can
be identified according to the most significant treatment factor. For instance, the
majority of PC lipids are seen to have more significant effects associated with salt
stress, while MGDG lipids have more significant effects associated with differences
in genotype.
The above assessment of individual factors extends the analysis obtained from
ANOVA to the mass univariate framework. In a similar way to a single univariate
analysis, a greater level of detail can be obtained by decomposing the explanatory
model structure. If each term within the linear model can be parameterised into a
set of one degree of freedom terms (or contrasts), than marginal assessment boils
down to a set of hypothesis tests that can be directly related to a treatment differ-
ence and hence traditional volcano plots can be used. In practice, this will rarely
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occur but as exemplified in the lipidomics experiment, contrasts can be included
to extract a greater level of detail. For example, rather than simply analysing the
factor associated with three levels of salt stress, this factor can be decomposed into
two parts in order to test for evidence of a linear trend and deviations from such a
trend in the quantitative levels of salt stress. Similarly, the factor associated with
four different genotypes of Arabidopsis can be decomposed into two parts in order
to test for a) differences in ecotypes (Eutrema vs. Others) and b) differences in
genotypes within the same ecotype (Columbia, Ta-0 and Shadara). These effects
are shown in Figure 7C and again groups of responses showing similar patterns can
be extracted.
It is clear that as more complex models are considered this approach of marginal
assessment becomes more involved. However, the generalised visualisations extend-
ing the interpretation of ANOVA into three dimensions (term, effect size, response)
can greatly aid the biological interpretation.
Discussion
In this paper, two methods have been introduced for incorporating multiplicity
corrections in a mass univariate analysis for non-trivial explanatory (treatment)
structures. Each approach has its own advantages and the choice between them will
depend upon the context of any analysis. The RFM approach has been shown to be
conservative in identifying statistically significant response variables, as multiplicity
is applied to the one-way test of the saturated model, whereas the MRF approach
overcomes this conservativeness through an inflation of the residual degrees of free-
dom due to a one-way test of the predictive model. Inflating the residual degrees
of freedom under MRF may not always be desirable and an alternative would be
to partition the treatment sums of squares into two parts, one associated with the
one-way treatment structure of the predictive model and the other associated with a
‘lack-of-fit’ term. In this way, a one-way test of the predictive model can be defined
whilst maintaining the residual degrees of freedom for which the experiment was
designed.
The approach to use will be influenced by the type of analysis used downstream.
Overall assessments (a single assessment per response), such as a single ranking,
a classification by predictive model or a categorisation of differentially expressed
vs. non-differentially expressed response variables naturally fit within the MRF
framework. In comparison, marginal assessments (multiple independent assessments
per response), such as individual treatment effects or an incorporation of contrast
effects are more naturally expressed in the RFM framework.
Alternative Approaches
In this paper, attention has been focussed on controlling the multiplicity of tests of
the full explanatory model over the R response variables, i.e. at the response vari-
able level within an experiment, through a stage-wise hypothesis testing procedure.
Alternatives to this stage-wise paradigm can be found in the literature, but have
limitations to the response-level interpretation. Specifically, rather than controlling
the FDR at the response-level, an alternative would be to correct for multiplicity
over the R responses for each of the p explanatory terms, i.e. at the explanatory
term level within an experiment.
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The na¨ıve approach might consider that for p explanatory terms over R response
variables, a total of R × p tests are required. As such, a global multiplicity correc-
tion over this full set of R × p tests could be applied. However, this approach will
be vastly over-conservative. Moreover, for all but the simplest form of correction,
interpretation becomes difficult as each of the explanatory terms for a single re-
sponse variable will be assessed at a different level of significance as, for example,
under a Benjamini-Hochberg correction. This prevents the use of a model-based
interpretation that combines statistical significance with biological relevance as in
the examples above.
In orthogonal balanced designs, it is conceivable that controlling multiplicity for
each explanatory term separately is desirable. Specifically, p separate multiplicity
corrections can be applied for each of the p explanatory terms. This then results
in the identification of groups of responses that are statistically significant for each
separate explanatory term as implemented in [15]. As with the approaches derived
in this paper, an additional model selection step can be included to base the multi-
plicity corrections on the predictive rather than saturated models. Applying these
approaches to the simulated data in scenario 1 (Section 4 of the Supplementary
Material in Additional file 1), large discrepancies can be seen, particularly in the
assessment of significance of the main effects. This is unsurprising, since this Model,
Subset, Filter (MSF) approach does not respect the ‘bottom-up’ marginality inter-
pretation of the ANOVA, with main effects potentially omitted without the prior
removal of the associated interaction terms. Moreover, the final interpretation be-
comes limited, as again one cannot analyse the output in a model-based framework
as the assessment of individual terms is not consistent within a response variable.
Both the global multiplicity corrections (for all R × p tests) and separate mul-
tiplicity corrections (over all p tests for each of R terms) are incorporated in the
limma package [24] for differential expression analysis of RNAseq and microarray
data.
Extensions
This paper has focussed attention on designed experiments where all terms within
a linear model are factors and the associated analysis can be extracted through
ANOVA. In practice, many ’omics datasets may be better suited to alternative
univariate analysis approaches such as linear mixed models (to account for unbal-
anced designs), linear and generalized linear models to account for covariates or
non-normal responses and hierarchical models to account for known dependence
structures. Regardless of the complexity of the individual univariate technique, so
long as there is a clear definition of a saturated and predictive model, the principles
introduced in this paper will hold.
Conclusions
Mass univariate approaches provide a valuable complement to multivariate tech-
niques to analyse and interpret ’omics data. In particular, univariate approaches
are often well developed for problematic data, for instance, in dealing with miss-
ing values, unequal replication, unbalanced designs and autocorrelated error struc-
tures, which can be difficult to incorporate in a multivariate setting. Moreover,
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mass univariate approaches enable statistical significance and biological relevance
to be assessed at an individual response variable level in addition to the profile level
assessment obtained through a multivariate analysis.
However, as demonstrated in this paper, when analysing ’omics data through a
mass univariate approach, a choice of procedures for incorporating multiplicity cor-
rections is available. To gain a deeper understanding of the mechanisms underlying
a particular response variable, it is particularly important to assess the full treat-
ment structure of the design rather than the simplified one-way analysis common
in the literature. When coupled with an approach to control the multiplicity rate,
different analysis approaches give more or less influence to either fitting the predic-
tive model or correcting for multiplicity. Thus, it is important to be aware of the
implicit choice that is being made.
It is often the case that as the number of responses increases, ‘simple’ and ‘easy to
interpret’ analyses are preferred. This often comes at the cost of statistical rigor, but
equally the interpretation of model-based approaches can be cumbersome. However,
models generally provide a deeper insight, for instance, defining the classification of
responses into subgroups based on the statistical significance of terms in a model
or clustering responses based on predictions in different conditions. Two different
procedures for obtaining the predictive model whilst also incorporating multiplicity
corrections have been introduced and illustrated on data. The approach to use will
be driven by the specific aims of the analysis, namely whether a marginal or overall
assessment is most appropriate.
Since this choice in methods arises due to the presence of non-trivial (more com-
plex) explanatory treatment structures, this consideration will become increasingly
important as the ability to include more complex treatment structures and collect
observational covariates becomes more accessible due to the influx of accessible
’omics technologies.
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Figures
Figure 1 Lipidomics dataset. An experiment to investigate the abundance of 131 lipid species
within 4 different Arabidopsis genotypes in 3 differing levels of salt stress. A) shows a heatmap of
the log2 abundance of all lipid species in each condition and B) depicts the factorial design
structure.
Figure 2 Pictorially representation of two approaches to incorporate multiplicity into non-trivial
explanatory structures. A) Option 1. Rank, filter, model (RFM). This approach first applies a
multiplicity correction to the one-way ANOVA obtained from the saturated model to filter out
non-significant responses and then applies a model selection step to obtain a response specific
predictive model. B) Option 2, Model, rank, filter (MRF). This approach first performs a model
selection step to obtain a response specific predictive model, from which a one-way ANOVA is
applied and corrected for multiplicity to filter out non-significant responses. C) For the two-factor
model in equation (5) with a 3x4 factorial treatment structure and a replication of 3, this shows
the relationship between the one-way ANOVA obtained from a saturated model (fixed variance
ratio of 2 and associated significance value of 0.075 – shown by the solid black line) and the
one-way ANOVA obtained from the predictive model (for an increasing interaction effect). Thus,
as the variance ratio of the interaction term (shown by the solid red line) decreases, the
associated p-value of the one-way ANOVA of the predictive model also decreases.
Figure 3 Simulation Study: Overall Type I and Type II error Under a B-H control of the FDR:
A) Boxplots showing the distribution of the percentage of responses (within a dataset) falsely
identified as having non-constant mean response and B) Boxplots showing the distribution of the
percentage of responses (within a dataset) falsely identified as having a constant mean response
over all treatment groups.
Figure 4 Simulation Study: Model misspecification Under a B-H control of the FDR: A)
Percentage of responses with the correct model specification identified from each of the RFM and
MRF approaches compared to the true generating process. B) Percentage of responses with a
model misspecification identified from each of the RFM and MRF approaches compared to the
true generating process. C) Percentage of responses that have been over-fitted (the fitted model
includes all terms from the true generating process with additional terms) under the RFM and
MRF approaches. D) Percentage of responses that have been under-fitted (the fitted model
includes only a subset of terms, and no others, from the true generating process) under the RFM
and MRF. A model misspecification is defined to be a model that differs from the true generating
process in a way not captured by over- or under-fitting. Red, green and blue correspond to
simulations of 500, 1000 and 20000 responses respectively.
Figure 5 Lipidomics Case Study: Overall Comparison A) Comparison of the ranking of the set of
lipid species obtained from the overall measure of statistical significance via the RFM approach
compared to the MRF approach. Lipids above the grey dashed line are ranked higher under RFM,
whereas lipids below the dashed line are ranked higher under MRF. Colour of points indicates the
associated type of each lipid species. B) Lipids ranked according to the overall test of significance
under MRF (one-way ANOVA of the predictive model). C) Lipids grouped according to the set of
effects included in the predictive model under MRF. D) Lipids ranked according to the overall test
of significance under RFM (one-way ANOVA of the saturated model). E) Lipids grouped
according to the set of effects included in the predictive model under RFM. Information provided
in tabular form in Additional File 2 of the Supplementary Material.
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Figure 6 Lipidomics Case Study: Overall Assessment under the MRF A) Coupling the overall
measure of statistical significance (of the one-way test under MRF after a Benjamini-Hochberg
multiplicity correction) with measures of biological relevance calculated as the predicted fold
change in abundance compared to the baseline treatment of no salt stress for the variety
Columbia (Col). B) Coupling the overall measure of statistical significance (of the one-way test
under MRF after a Benjamini-Hochberg multiplicity correction) with a generalised measured of
biological relevance calculated as the maximal fold increase (or decrease) under any treatment
condition compared to the baseline treatment of no salt stress for the variety Columbia (Col). Red
lines indicate a p-value of 0.05. Green lines indicate a fold change of 4.
Figure 7 Lipidomics Case Study: Marginal Assessment under the RFM A) Generalised volcano
plots for each explanatory treatment term within the saturated model, where the term specific
p-value has been adjusted via the corresponding one-way multiplicity correction under RFM and
biological relevance is defined through the treatment mean square. B) Heatmap of the term
specific p-values (−log10(p)) adjusted via the corresponding one-way multiplicity correction under
RFM. Grey indicates an adjusted p-value < 0.05. C) Heatmap of the term specific p-values
(−log10(p)) for the extended contrast model adjusted via the corresponding one-way multiplicity
correction under RFM. Grey indicates a non-significant adjusted p-value < 0.05.
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